Product: neurolens Measurement Device, Gen 2 (nMD2)
Top Line: The neurolens Measurement Device, Gen 2 (nMD2) offers “an objective, accurate and repeatable way to measure binocular vision or, more specifically, eye alignment,” according to neurolens.
Close Up: Employing over 10,000 data points per patient, the cutting-edge eye tracking system can identify eye misalignment as small as 0.1 Prism Diopters. The diagnostic information from the nMD2 is used to prescribe neurolenses with patented Contoured Prism technology, which bring the eyes into alignment, relieving the headaches, neck and shoulder pain, eye strain, dry eye and dizziness that many people experience when using their near vision.
“We are an outcomes company first and foremost, and the nMD2 will enable even more eyecare providers to offer the pain-relieving comfort of neurolenses to their patients,” said Davis Corley, CEO of neurolens. “Vision care must evolve beyond visual acuity to address the needs of patients in the digital age. Innovative technology like the nMD2 is the path to unlocking a new dimension of visual comfort,” Corley added.
Vital Stats: The nMD2 is 80 percent smaller than the first-generation nMD, making it easy to incorporate into any practice space. The diagnostic test on the nMD2 is also 35 percent faster, maximizing pre-test efficiency and overall patient flow. The nMD2 employs state-of-the-art technology such as USB 3.0 cameras to support faster eye tracking and increased fields of vision, allowing for additional testing capabilities and providing a more immersive patient experience.
Most clinical testing routines for evaluating binocular vision are subjective, depending on either the patient’s attentive response or the clinician’s level of expertise. This subjectivity can lead to inaccuracy and poor repeatability. Measurements from the nMD2, however, are not impacted by the examiner’s level of expertise or the patient’s responsiveness. In fact, the nMD2 can be operated by a technician at any experience level, making this technology accessible to any eyecare practice, neurolens said.
The nMD2 will be commercially available on July 1, 2021, but neurolens will start taking orders immediately as part of a pre-sale offer.
www.neurolenses.com